The abbreviations used are: Chk2: checkpoint kinase 2; ATM, ataxia telangiectasia mutated protein; LFS: Li-Fraumeni syndrome; FHA: forkhead homology-associated.
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Introduction:
The maintenance of genomic integrity following DNA damage depends on the coordination of DNA repair and the controls of cell cycle progression. Chk2/hcds1, a mammalian homologue of the Saccharomyces cerevisiae Rad53 and Schizosaccharomyces pombe Cds1 genes, plays a critical role in DNA damage signaling pathways (1-5). Downstream of ATM in response to gamma radiation (1,4,6), Chk2 directly phosphorylates and regulates the functions of p53 and BRCA1 (7) (8) (9) (10) (11) . Moreover, heterozygous germ-line mutations in Chk2 have been identified in a subset of patients with Li-Fraumeni syndrome, a highly penetrant familial cancer phenotype (12). These studies strongly suggest that, like p53, Chk2 is a tumor suppressor gene.
Several mutations of Chk2 were identified in patients with Li-Fraumeni syndrome and in sporadic colon cancer. Although it has been speculated that these Chk2 mutants are defective in their tumor suppressor functions (12), this possibility has not been addressed directly. Here, we report the biochemical characterization of all four reported Chk2 mutations.
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Materials and methods
Constructs:
Dr. Jann Sarkaria kindly provided plasmid for the expression of HA-tagged Chk2 in mammalian cells (13) . Site-directed mutagenesis (Promega) was performed to introduce mutations in Chk2 coding sequence. For expressing wild type or mutant Chk2 as glutathione-Stransferase (GST)-fusion proteins in insect cells, wild type or mutant Chk2 coding sequence was cloned into pDONR201 vector (Gibco BRL). Gateway cloning technology (Gibco BRL) was used to sub-clone these coding sequences into pDEST20 vector, a vector for baculovirus expression of GST-fusion proteins. Recombinant baculoviruses encoding GST-fused wild type and mutants of Chk2 were generated using Bac-to-Bac baculovirus system (Gibco BRL).
Cell Lines and Culture Conditions
All cell lines were obtained from American Tissue Culture Collection (ATCC) and cultivated in RPMI 1640 (Biofluids) supplemented with 10% fetal bovine serum. To establish cell lines stably expressing HA-tagged wild type or mutant Chk2, HCT116 cells were transfected with plasmids encoding the indicated HA-tagged sequences. G418 resistant clones were isolated and analyzed by Western blotting using either anti-HA antibody or anti-Chk2 antibody. Clones that express HA-tagged Chk2 at levels similar to that of endogenous Chk2 were used in this study. Where indicated, cells were exposed to gamma radiation from a 137 Cs source at a dose of Wild type or mutant Chk2 was purified using glutathione affinity chromatography.
Immunoprecipitation, immunoblotting and kinase assays
Preparation of cell lysates, immunoprecipitation and immunoblotting were performed as described previously (14) . Anti-HA antibody HA11 was purchased from Babco. Antibodies against Chk2 were raised against Glutathione-S-transferase (GST)-fusion proteins containing full length Chk2 (mAB#7) or raised against a GST-fusion protein containing C-terminus of Chk2
(residues 193-543; anti-Chk2B). Anti-Chk2 Thr-68 phospho-specific antibodies were provided by Dr. Bin-Bing Zhou. Chk2 kinase assays were performed as described previously (13) . and run in the same buffer with a flow-rate of 0.5 ml/minute. For each run, a sample of 500 µl was injected and 500 µl fractions were collected. For column equilibration, lowand high-molecular-weight gel filtration calibration kits (Pharmacia) were used and the column was run under identical conditions. 6
Size fractionation of native Chk2 complexes
Results:
Frameshift mutations at the C-terminus of Chk2 lead to the loss of Chk2 kinase activity.
Since Chk2 is a DNA damage-activated protein kinase that participates in the phosphorylation of several substrates, including Cdc25C, p53 and BRCA1, we first examined the kinase activity of Chk2 mutants. Using site-directed mutagenesis, we generated four Chk2 mutants ( Figure 1 ) that have been previously reported (12). Wild type and mutant GST-Chk2 proteins were expressed in insect cells, purified using glutathione-Sepharose beads, and kinase activities were assessed using GST-Cdc25C
(residues 200-256) as a substrate. As shown in Figure 2 , one FHA domain mutant (I157T) exhibits wild type activity. In contrast, the other FHA domain mutant (R145W) has reduced catalytic activity, and the two frame-shift mutants lack kinase activity.
R145W mutant of Chk2 is not phosphorylated or activated following gamma radiation.
Chk2 is activated following DNA damage (1) Western blotting using anti-Thr-68 phospho-specific antibody. In agreement with its activation following gamma radiation, ectopically expressed HA-Chk2 was phosphorylated at Thr-68 (Figure 3c ). Also consistent with the above findings that HAChk2 harboring I157T mutation, but not R145W mutation, can be activated by DNA damage (Figure 3b ), the I157T mutant was phosphorylated at Thr-68 whereas the R145W mutant was not (Figure 3c ). In addition, expression of the R145W mutant did not affect the phosphorylation of endogenous Chk2 in these cells (Figure 3c ), suggesting that the mutant protein may not exhibit dominant negative activity.
FHA domain mutants of Chk2 localize normally in nuclei.
Chk2 normally localizes to nuclei. We examined the sub-cellular localization of wild type and mutant HA-tagged Chk2 stably expressed in HCT116 derivative cell lines. In this study, we have characterized all four reported Chk2 mutations. Two mutations identified in Li-Fraumeni patients that lead to frame-shifts at the C-terminal kinase domain, result in loss of kinase activity. In contrast, the R145W Chk2 mutant still retains some kinase activity in vitro, but is incapable of being activated following gamma radiation in vivo, most likely because it is not phosphorylated at Thr-68 by ATM kinase.
This mutant also behaves different from wild type Chk2 in size fractionation experiments, suggesting that this mutation may also affect associations of Chk2 with other cellular proteins.
The I157T Chk2 mutant behaves as wild type Chk2 in all the assays used in this study. The I157T mutation may be a rare polymorphism that does not affect Chk2 Extracts were prepared from indicated cell lines before and 1 hour after gamma radiation. HAtagged wild type or mutants Chk2 were immunoprecipitated using anti-HA antibodies and kinase reactions were performed using GST-Cdc25C as substrate. c) Thr-68 is not phosphorylated in R145W mutant following gamma radiation. Extracts were prepared as described above.
Immunoprecipitates with anti-Chk2 antibodies or anti-HA antibodies were immunoblotted with anti-phospho-Thr 68 antibodies and anti-Chk2 or anti-HA antibodies. HCT15 has no detectable Chk2 kinase activity before or after gamma radiation. Extracts were prepared from indicated cell lines before and 1 hour after gamma radiation. Kinase reactions were performed using anti-Chk2B immunoprecipitates. 
